AbCellera Biologics (ABCL)

Company Profile

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development.

Company profile

Ticker

ABCL

Exchange

NASDAQ

Website

www.abcellera.com

CEO

Carl L.G. Hansen

Incorporated

British Columbia, Canada

Location

British Columbia, Canada

Fiscal year end

Dec 31

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co • Abbott Laboratories • Teva- Pharmaceutical Industries • Bristol-Myers Squibb • Lilly(Eli) & Co • Viatris • Abbvie • Bausch Health Companies ...

SEC CIK

0001703057

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

AbCellera Australia Pty Ltd. • AbCellera Biologics UK Ltd. • AbCellera Boston, Inc. • AbCellera Properties Inc. • AbCellera Properties Columbia Inc. • AbCellera Properties Evans Inc. • AbCellera US, Inc. • Biologiques AbCellera Québec Inc. • Lineage Biosciences Inc. • Trianni Inc. ...

ABCL stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Average target

$25.00

Low target

$18.00

High target

$32.00

Latest filings (excl ownership)

View all

8-K

Regulation FD Disclosure

10 Mar 23

S-8

Registration of securities for employees

21 Feb 23

AbCellera Reports Full Year 2022 Business Results

8 Nov 22

AbCellera Reports Q3 2022 Business Results

8 Nov 22

EFFECT

Notice of effectiveness

9 Aug 22

Results of Operations and Financial Condition

Transcripts

View all

ABCL

Earnings call transcript

2022 Q4

21 Feb 23

ABCL

Earnings call transcript

2022 Q3

8 Nov 22

ABCL

Earnings call transcript

2022 Q2

10 Aug 22

ABCL

Earnings call transcript

2022 Q1

11 May 22

ABCL

Earnings call transcript

2021 Q4

25 Feb 22

ABCL

Earnings call transcript

2021 Q3

10 Nov 21

ABCL

Earnings call transcript

2021 Q2

13 Aug 21

ABCL

Earnings call transcript

2021 Q1

14 May 21

ABCL

Earnings call transcript

2020 Q4

30 Mar 21

Latest ownership filings

View all

Carl L. G. Hansen

23 Feb 23

SC 13G/A

Capital World Investors

Change in insider ownership

Financial summary

Financial statements Chart ABCL financial data

Quarter (USD)	Dec 22	Sep 22	Jun 22	Mar 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	411.54 mm	411.54 mm	411.54 mm	411.54 mm	411.54 mm	411.54 mm
Cash burn (monthly)	(no burn)	7.47 mm	12.59 mm	(no burn)	(no burn)	(no burn)
Cash used (since last report)	n/a	22.25 mm	37.52 mm	n/a	n/a	n/a
Cash remaining	n/a	389.29 mm	374.02 mm	n/a	n/a	n/a
Runway (months of cash)	n/a	52.1	29.7	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q4 2022

ABCL institutional ownership history Ownership history

69.7% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	197	185	+6.5%
Opened positions	36	40	-10.0%
Closed positions	24	16	+50.0%
Increased positions	76	69	+10.1%
Reduced positions	55	38	+44.7%

13F shares	Current	Prev Q	Change
Total value	1.25 tn	2.41 bn	+51576.9%
Total shares	200.62 mm	188.73 mm	+6.3%
Total puts	583.70 k	729.40 k	-20.0%
Total calls	1.12 mm	4.13 mm	-72.7%
Total put/call ratio	0.5	0.2	+193.6%

Largest owners	Shares	Value	Change
Carl L. G. Hansen	55.86 mm	$0.00	+3.8%
Baillie Gifford & Co	19.70 mm	$199.53 bn	+47.5%
BLK Blackrock	13.85 mm	$140.32 bn	+10.2%
Voya Investment Management	11.01 mm	$111.58 bn	+2.2%
Baker Bros. Advisors	10.45 mm	$105.86 bn	0.0%
Thiel Peter	10.18 mm	$478.35 mm	0.0%
Capital World Investors	9.33 mm	$94.49 bn	-2.6%
DCVC Bio	7.31 mm	$0.00	0.0%
Orbimed Advisors	4.18 mm	$42.35 bn	0.0%
Harvard Management	4.11 mm	$41.58 bn	0.0%

Largest transactions	Shares	Bought/sold	Change
Baillie Gifford & Co	19.70 mm	+6.34 mm	+47.5%
STT State Street	3.27 mm	+3.27 mm	NEW
Carl L. G. Hansen	55.86 mm	+2.05 mm	+3.8%
Guardian Capital Advisors	1.79 mm	-1.95 mm	-52.2%
BLK Blackrock	13.85 mm	+1.28 mm	+10.2%
Citadel Advisors	1.46 mm	+968.45 k	+195.0%
Renaissance Technologies	2.12 mm	-858.40 k	-28.8%
American Century Companies	1.29 mm	+713.00 k	+123.9%
Norges Bank	646.70 k	+646.70 k	NEW
Casdin Capital	2.27 mm	+620.00 k	+37.6%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

ABCL insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
22 Feb 23	Carl L. G. Hansen	Common Shares	Option exercise	Acquire M	No	No	2.7	56,125	151.54 k	505,125
22 Feb 23	Carl L. G. Hansen	Share option Common Shares	Option exercise	Dispose M	No	No	2.7	56,125	151.54 k	6,557,566
20 Dec 22	Andrew Booth	Common shares	Gift	Dispose G	No	No	0	50,000	0.00	138,500
20 Dec 22	Andrew Booth	Common Shares	Option exercise	Acquire M	No	No	0.19	50,000	9.50 k	188,500
20 Dec 22	Andrew Booth	Share option Common shares	Option exercise	Dispose M	No	No	0.19	50,000	9.50 k	5,820,481
16 Dec 22	Thermopylae	Common Shares	Buy	Acquire P	No	No	10.0967	85,102	859.25 k	55,859,493
1 Dec 22	Carl L. G. Hansen	Share Options Common Shares	Grant	Acquire A	No	No	13.18	925,069	12.19 mm	6,613,691
1 Dec 22	Andrew Booth	Share Options Common Shares	Grant	Acquire A	No	No	13.18	485,661	6.40 mm	5,870,481